meglumine antimoniate has been researched along with Leishmaniasis, Visceral in 309 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (19.09) | 18.7374 |
| 1990's | 88 (28.48) | 18.2507 |
| 2000's | 78 (25.24) | 29.6817 |
| 2010's | 71 (22.98) | 24.3611 |
| 2020's | 13 (4.21) | 2.80 |
| Authors | Studies |
|---|---|
| Aguiar-Soares, RDO; Andrade, HM; Brito, RCF; Cardoso, JMO; Frézard, F; Mathias, FAS; Ostolin, TLVDP; Ramos, GS; Reis, AB; Reis, LES; Roatt, BM; Vieira, JFP | 1 |
| Campos, MP; Figueiredo, FB; Gonçalves, AS; Gonçalves, G; Medeiros, LCS | 1 |
| Chiheb, S; Dahbi, HS; Darif, D; El Idrissi Saik, I; Fatoiki, FZE; Hali, F; Hammi, I; Kihel, A; Riyad, M; Soussi Abdellaoui, M; Tazi Saoud, Z | 1 |
| Broere, F; de Jong, MK; Piek, CJ; Rappoldt, A | 1 |
| Friedman, A; Siewe, N | 1 |
| Daza González, MA; Fermín Rodríguez, M; Fragío Arnold, C; Miró, G; Rupérez Noguer, C | 1 |
| Apostolidis, K; Buono, A; Chatzis, MK; Kasabalis, D; Leontides, LS; Petanides, T; Polizopoulou, ZS; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG | 1 |
| da Silva Praxedes, MF; Margotto Bertollo, C; Moreira Reis, AM; Parreiras Martins, MA; Serbate Borges Portela, Á; Silva Brasileiro, SA | 1 |
| Arbeláez, N; Montoya, A; Moreno, J; Murillo, J; Robledo, SM; Vélez, A; Vélez, ID | 1 |
| Camara, L; Queirós, J; Ribeiro, R; Teófilo, E | 1 |
| Cunha, MAD; Luz, KG; Shaw, JJ; Sousa, ASV; Vechi, HT | 1 |
| Apostolidis, K; Athanasiou, LV; Chatzis, MK; Ikonomopoulos, J; Kasabalis, D; Leontides, LS; Mataragka, A; Petanides, T; Saridomichelakis, MN; Xenoulis, PG | 1 |
| Alves, RB; Colombo, FA; da Silva, JC; de Freitas, RP; Gontijo, VS; Laurenti, MD; Malaquias, LCC; Marques, MJ; Nunes, JB | 1 |
| Alcover, MM; Basurco, A; Fani, C; Fernández, A; Fisa, R; Giner, J; Riera, C; Trotta, M; Verde, MT; Villanueva-Saz, S; Yzuel, A | 1 |
| Bitam, I; Davoust, B; Hamidat, HK; Lafri, I; Laidoudi, Y; Lounas, A; Mediannikov, O; Medkour, H; Mekroud, A; Varloud, M | 1 |
| Chatzis, MK; Kasabalis, D; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG | 1 |
| Alves, FP; Amaral, TA; Costa, CHN; Costa, DL; de Almeida, RP; de Carvalho, AL; de Carvalho, SFG; de Melo, EV; Leite, RD; Lima, SS; Rabello, A; Rode, J; Romero, GAS; Sousa, AQ | 1 |
| Alexandre-Pires, G; Alves-Azevedo, R; de Jesus, J; Ligeiro, D; Lopes-Ventura, S; Pereira da Fonseca, I; Pereira, MA; Rafael-Fernandes, M; Rodrigues, A; Santos, M; Santos-Gomes, G; Santos-Mateus, D; Tomás, AM; Valério-Bolas, A | 1 |
| Baneth, G; Marí-Martorell, D; Martínez-Orellana, P; Montserrat-Sangrà, S; Ordeix, L; Solano-Gallego, L | 1 |
| Singh, A; Sundar, S | 1 |
| Cordeiro-da-Silva, A; Dantas-Torres, F; Miró, G; Travi, BL | 1 |
| Azevedo, EG; Caliari, MMV; Castro, RS; de Amorim, IFG; Demicheli, C; Frezard, FJG; Michalick, MSM; Mosser, DM; Pereira, RA; Pinheiro, LJ; Pinto, AJW; Silva, SM; Tafuri, WL | 1 |
| Acedo-Sánchez, C; Corpas-López, V; Díaz-Sáez, V; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Márquez, F; Navarro-Moll, MC | 1 |
| Carneiro de Freitas, JC; Macedo Rondon, FC; Maia de Morais, S; Pereira Mendes, FN; Pinto Vieira, ÍG; Vieira-Araújo, FM | 1 |
| Bernal, LJ; Cantos-Barreda, A; Cerón, JJ; Escribano, D; Martínez-Subiela, S; Tecles, F | 1 |
| Clavijo, A; Gavilan, C; González de Dios, J; Moral, L; Ramos, JM; Salvador, T | 1 |
| Borborema, SET; de Andrade Junior, HF; do Nascimento, N; Osso Junior, JA; Tempone, AG | 1 |
| Almeida, TC; da Silva, ATP; da Silva, GN; Perasoli, FB; Rezende, SA; Silva, DF; Silva, SC | 1 |
| Carbone, DCB; Carvalho, CME; Cônsolo, FZ; Muller, KTC; Reis, VQD; Sanches, SC; Silva, MC; Zanoni, LZG | 1 |
| Cerón, JJ; Checa, R; Daza González, MA; Fermín Rodríguez, M; Fragío Arnold, C; Martínez Subiela, S; Miró, G; Montoya, A; Portero Fuentes, M; Rupérez Noguer, C | 1 |
| de Carvalho, IPSF; de Oliveira, MRF; Peixoto, HM; Romero, GAS | 1 |
| Chatzis, MK; Kasabalis, D; Petanides, T; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG | 2 |
| Campino, L; Henriques, S; Maia, C; Marques, M; Nunes, M; Rolão, N | 1 |
| Campos, PP; Demicheli, C; Dias Corrêa-Junior, J; Frézard, F; Kato, KC; Morais-Teixeira, E; Rabello, A; Reis, PG; Salaün, P; Silva-Barcellos, NM | 1 |
| Mesquita, JT; Reimão, JQ; Tempone, AG | 1 |
| Batista, MA; Castro, RA; Ferreira, FM; Frézard, F; Moura, SA; Rezende, SA; Rossi, FM; Silveira-Lemos, D | 1 |
| Chicharro, C; Lombardo, G; Lupo, T; Pennisi, MG; Solano-Gallego, L | 1 |
| Ansari, S; Behnam, B; Mohebali, M; Sayyahfar, S | 1 |
| Aoun, K; Benikhlef, R; Bouratbine, A; Faraut, F; Harrat, Z; Jeddi, F; Marty, P; Mary, C; Piarroux, R; Pomares, C; Pratlong, F | 1 |
| Azevedo, EG; da Silva, SM; de Oliveira E Castro, RA; de Souza, LE; Demicheli, C; Ferreira, AA; Ferreira, CS; Frézard, F; Rezende, SA; Ribeiro, RR | 1 |
| Alves, MP; Daher, EF; Henn, GA; Martins, AM; Meneses, GC; Montenegro, BL; Oliveira, MJ; Rocha, HA; Sampaio, AM; Silva, GB | 1 |
| Calvi, SA; da Silva, LD; de Abreu, MM; de Assis Golim, M; de Campos Soares, ÂM; Fortaleza, CM; Gatto, M; Simão, JC; Tasca, KI | 1 |
| Bhattacharjee, H; Charret, KS; Mandal, G; Mandal, S; Mukhopadhyay, R; Papadopoulou, B; Sharma, M | 1 |
| de Arias, AR; Lima, AP; Maldonado, M; Pandolfi, E; Schinini, A; Serna, ME; Torres, S | 1 |
| Aoun, K; Harrat, Z; Laamrani El Idrissi, A; Marty, P | 1 |
| Aydın Teke, T; Bayhan, Gİ; Gayretli Aydın, ZG; Metin Timur, Ö; Mungan, M; Öz, N; Tanır, G; Yılmaz, N | 1 |
| Chahed, J; Chouchène, C; Ksia, A; Mekki, M; Nouri, A | 1 |
| Çakalağaoğlu, F; Demirdal, T; El, S; Kaptan, F; Örmen, B; Özkan Çayıröz, P; Sezak, N; Türker, N; Ural, S; Vardar, İ | 1 |
| Khamesipour, A; Mohammadi, AM; Nateghi Rostami, M; Seyyedan Jasbi, E | 1 |
| Abdolahi Khabisi, S; Davami, MH; Ghatee, MA; Naraki, T; Sarkari, B | 1 |
| Altet, L; Di Filippo, L; Martínez-Orellana, P; Montserrat, S; Ordeix, L; Planellas, M; Roura, X; Solano-Gallego, L | 1 |
| Alonso, S; Laamrani El Idrissi, A; Najdi, A; Nejjari, C; Picado, A; Sicuri, E; Tachfouti, N | 1 |
| Castanys, S; Corpas-López, V; Gamarro, F; García-Hernandez, R; Gómez Pérez, V; Martín-Sanchez, J; Tomás, AM | 1 |
| Behdani, R; Mazloum Farsi Baf, M; Sasannejad, P; Zabolinejad, N | 1 |
| Alcántara, G; Checa, R; Chicharro, C; Cruz, I; de Quadros, LP; Gálvez, R; Hernández, L; Jiménez, MÁ; Mateo, M; Miró, G; Montoya, A | 1 |
| Barbosa, JF; Caligiorne, RB; de Figueiredo, SM; Lyon, S | 1 |
| Guo, Q; Liao, Q; Miao, R; Shu, M; Wan, C; Wang, Z; Wen, Y; Zhu, Y | 1 |
| Caljon, G; Croft, SL; Guerin, PJ; Hendrickx, S; Maes, L | 1 |
| Alborzi, A; Attar, A; Falahi, F; Jafarpour, Z; Kadivar, MR; Karimi, A; Pouladfar, G | 1 |
| Ashkan, MM; Rahim, KM | 1 |
| Caligiorne, RB; de Assis, TS; Rabello, A; Romero, GA | 1 |
| Alborzi, A; Fakhar, M; Hatam, GR; Kadivar, MR; Motazedian, MH; Pouladfar, GR | 1 |
| Aragão, EB; Arruda, GA; Daher, EF; Evangelista, LF; Galeano, NM; Lima, RS; Mota, RM; Oliveira, RA; Silva Júnior, GB; Silva, SL | 1 |
| Arnedo-Pena, A; Bellido-Blasco, JB; Herrero-Carot, C; Romeo-García, MA | 1 |
| Avallone, L; Cestaro, A; Ciaramella, P; Cortese, L; Di Loria, A; Lombardi, P; Pelagalli, A; Piantedosi, D | 1 |
| García-Lázaro, M; Natera, C; Rivero, A; Villar, C | 1 |
| Brustoloni, YM; Cônsolo, CE; Melnikov, P; Zanoni, LZ | 1 |
| Alborzi, A; Shahian, M | 1 |
| Bóia, MN; Brustoloni, YM; Cunha, RV; Dorval, ME; Fernandes, TD; Oliveira, AL | 1 |
| Buffet, PA; Bullani, R; de Vallière, S; Gillmore, JD; Greub, G; Joneberg, JE; Mary, C; Rotman, S; Tarr, PE | 1 |
| Daher, EF; Fonseca, PP; Gerhard, ES; Leitão, TM; Silva Júnior, GB | 1 |
| Amri, F; Aoun, K; Ben Alaya, N; Bouratbine, A; Chouihi, E; Mary, C; Raies, A | 1 |
| Battikh, R; Belhadj, R; Berraies, N; Gargouri, S; Haloues, M; Harzallah, K; Hmida, J; Jemli, B; Manaa, J | 1 |
| Arik Yilmaz, E; Tanir, G; Taylan Ozkan, A; Tuygun, N | 1 |
| Alvar, J; Balasegaram, M; Boelaert, M; Lynen, L; Meheus, F; van Griensven, J | 1 |
| Abbehusen, M; de Jesus, RS; Goto, Y; Guderian, J; Howard, RF; Nakatani, M; Netto, EM; Pedral-Sampaio, G; Reed, SG; Trigo, J | 1 |
| Abreu, KL; Daher, EF; Franco, LF; Garcia, AV; Libório, AB; Mota, RM; Oliveira, MJ; Rocha, NA; Silva Júnior, GB | 1 |
| Benslama, A; Charra, B; Ezzouine, H; Motaouakkil, S | 1 |
| García Esteban, C; García-Bermejo, I; Guillén Martín, S; La Orden Izquierdo, E; Prieto Tato, LM; Ramos Amador, JT; Salcedo Lobato, E | 1 |
| Brustoloni, YM; Cônsolo, LZ; Cunha, RV; Dorval, ME; Oliveira, AL; Oshiro, ET | 1 |
| Alexandrino-de-Oliveira, P; da Cunha, RV; Da-Costa, Fd; Da-Cruz, AM; Dorval, ME; Paniago, AM; Pereira, GR; Santos-Oliveira, JR | 1 |
| Foto, E; Gradoni, L; Kuneshka, L; Petrela, R; Zavalani, F | 1 |
| Balasegaram, M; Hailu, A; Hailu, W; Hurissa, Z; Omollo, R; Tafes, H; Weldegebreal, T; Yifru, S | 1 |
| Boughamoura, L; Bouguila, J; Chabchoub, I; Essoussi, AS; Mlika, A; Moncef, Y; Saghrouni, F | 1 |
| Butsashvili, M; Chubabria, G; Kajaia, M; Kamkamidze, G; Kokaia, N; McNutt, LA; Morse, DL; Zenaishvili, O | 1 |
| Abderrahim, E; Bacha, MM; Bahloul, A; Ben Abdallah, T; Ben Maïz, H; Chaouech, D; Cherif, M; Khaled, S; Kheder, A; Ounissi, M; Rajhi, H; Trabelsi, S; Turki, S; Znaidi, N | 1 |
| Giudice, E; Passantino, A | 1 |
| Amaral, V; Campos, MC; Canto-Cavalheiro, MM; Charret, KS; Dos Reis, C; Echevarria, A; Leon, LL; Rodrigues, RF | 1 |
| Korkmaz, M; Özbel, Y; Şakru, N; Töz, SÖ | 1 |
| Aït-Oudhia, K; Dedet, JP; Gazanion, E; Lachaud, L; Oury, B; Pratlong, F; Sereno, D | 1 |
| Amorim, IF; Azevedo, EG; da Silva, SM; Demicheli, C; Frézard, F; Gontijo, NF; Melo, MN; Michalick, MS; Ribeiro, RR; Tafuri, WL | 1 |
| Albuquerque, C; Campino, L; Cardoso, L; Dias, I; Machado, J; Pires, MA; Requicha, J; Sargo, T; Viegas, C | 1 |
| Civitella, C; Guglielmini, C; Luciani, A; Sconza, S | 1 |
| Abreu, KL; Alves, MP; Daher, EF; Franco, LF; Jacinto, CN; Júnior, GB; Montenegro, BR; Oliveira, MJ; Rocha, NA; Sampaio, AM; Vieira, AP | 1 |
| Chakravarty, J; Sundar, S | 1 |
| Alborzi, A; Ghadimi Moghadam, A; Pouladfar, G; Pourabbas, B; Rezaee, Z | 1 |
| Abebe, Y; Abraham, Y; Ali, A; Berhe, N; Hailu, A; Mengistu, G; Tsige, K | 1 |
| Costa Val, AP; Demicheli, C; Frézard, F; Melo, MN; Michalick, MS; Rocha, OG; Schettini, DA; Souza, LF | 2 |
| Badaró, R; Bittencourt, A; Follador, I; Nunes, VL; Silva, N; Straatmann, A | 1 |
| Garnier, JM; Horelt, A; Minodier, P; Retornaz, K | 1 |
| Ali, IH; Ben Abdallah, N; Ben Maïz, H; Ben Moussa, F; Ben Salem, L; Cherif, L; el Younsi, F; Khiari, K; Maazoun, I; Turki, S | 1 |
| Alvar, J; Clotet, B; Jiménez-Mejías, ME; Laguna, F; López-Vélez, R; Prados, D; Ribera, E; Sirera, G; Sust, M; Torre-Cisneros, J; Videla, S | 1 |
| Bernal, LJ; Cerón, JJ; Martínez-Subiela, S | 1 |
| BOIX BARRIOS, J | 1 |
| BERNARD, R; GIRAUD, P; VINCENT, P | 1 |
| MATOS, J; VELASCO, JA | 1 |
| CARVALHO, O | 1 |
| PI FERRER, A; SALA GINABREDA, JM; WOESSNER CASAS, S | 1 |
| CAMBI, P | 1 |
| Gradoni, L; Gramiccia, M; Scalone, A | 2 |
| DURAND, P | 1 |
| BOULARD, C; MASSONNAT, J; PORTIER, A | 1 |
| RIPA, F; TONDI, IV | 1 |
| Bongrand, MC; Chochoi, N; Faraut, F; Gallais, H; Gensollen, S; Monges, P; Montana, M; Ravaux, I; Timon-David, P | 1 |
| Garnier, JM; Minodier, P; Retornaz, K; Robert, S | 1 |
| di Martino, L; Di Muccio, T; Gradoni, L; Gramiccia, M; Occorsio, P; Scalone, A | 1 |
| Colomba, C; Frasca Polara, V; Salsa, L; Scarlata, F; Titone, L | 1 |
| Aste, N; Atzori, L; Ferreli, C; Pistis, P; Zucca, M | 1 |
| Amari, L; Belhaj, S; Ben Chaabene, T; Goubontini, A; Kilani, B | 1 |
| Delis, D; Kafetzis, DA; Liapi, G; Mavrikou, M; Stabouli, S; Velissariou, IM | 1 |
| Garcia-Cordoba, F; Gonzalez Diaz, G; Ortuño, FJ; Segovia, M | 1 |
| Aguar, MC; Díaz-Gómez, JR; Lapuebla, X; Rovira, RE | 1 |
| Dugas, B; Mazier, D; Pino, P; Rougier, S; Vouldoukis, I; Woehrlé, F | 1 |
| Aste, G; Boari, A; Di Tommaso, M; Steiner, JM; Williams, DA | 1 |
| Ahmed, I; Ahmed, P; Altaf, C; Anwar, M; Ashraf, T | 1 |
| Affronti, M; Di Rosa, S; Malta, R; Renda, M; Rini, GB; Rubino, ME; Trifirò, G; Vassallo, L | 1 |
| Cascio, A; Giordano, S; Mancuso, G; Scarlata, F; Titone, L | 1 |
| Aquino, D; Barral, A; Barral-Netto, M; Brodskyn, C; Caldas, A; Costa, J; Favali, C; van Weyenbergh, J; Vinhas, V | 1 |
| Dzhokhtaberidze, TG; Khochava, MA; Lomtadze, ML; Shalamberidze, IA; Shilakadze, MA | 1 |
| Aquino, D; Barral, A; Barral-Netto, M; Caldas, AJ; Costa, J; Silva, AA | 1 |
| Abdi, K; Darabi, M; Ghareghozloo, B; Kariminia, A; Solgi, G | 1 |
| Boumis, E; Chinello, P; Della Rocca, C; Paglia, MG; Petrosillo, N; Proietti, MF | 1 |
| Djossou, F; Ibanez, C; Le Bras, M; Longy-Boursier, M; Malvy, D; Vatan, R | 1 |
| Bonello, FL; de Lima, VM; Feitosa, MM; Ikeda-Garcia, FA; Lopes, RS; Marques, FJ; Morinishi, CK; Perri, SH; Zanette, MF | 1 |
| Carvalho, SF; Costa, RT; De Almeida Silva, L; Nascimento, E; Prata, A; Rodrigues, V; Romero, HD | 1 |
| Gómez-Rodríguez, F; Gómez-Soto, F; Molina-Ruano, FJ; Puerto-Alonso, JL | 1 |
| Ciarlini, PC; Feitosa, MM; Ikeda-Garcia, FA; Lima, VM; Lopes, RS; Marques, FJ; Perri, SH | 1 |
| Kumar, PV; Mousavi, A; Rizvi, MM; Sadeghi, E; Sadeghipour, A; Soleimanpour, H; Tabatabaei, AH; Vasei, M | 1 |
| Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M | 1 |
| Brooker, S; Chappuis, F; Kabatereine, N; Kolaczinski, JH; Onapa, A; Reithinger, R; Worku, DT | 1 |
| Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL | 1 |
| Avallone, L; Ciaramella, P; Cortese, L; Di Loria, A; Lombardi, P; Mastellone, V; Pelagalli, A; Piantedosi, D | 1 |
| Ammari, L; Belhadj, S; Ben Chaabene, T; Chaker, E; Kanoun, F; Kilani, B; Tiouiri, H; Toumi, A | 1 |
| Baena, V; Cañavate, C; Cruz, I; Gilaberte, M; Pujol, RM; Yébenes, M | 1 |
| Cavailler, P; Chappuis, F; Couffignal, S; Loutan, L; Mueller, Y; Nguimfack, A; Rwakimari, JB | 1 |
| Campos Neto, A; da Costa, RT; Dias, ES; França, JC; Fujiwara, RT; Mayrink, W; Miret, J; Nascimento, E; Reed, S; Sampaio, W; Vale, A; Vieira, E | 1 |
| Belaabidia, B; El Biaz, S; Essaadouni, L; Hamdaoui, A; Zahlane, M | 1 |
| Compagnoni, F; Franceschi, A; Mancianti, F | 1 |
| Alves, CF; Demicheli, C; Frézard, F; Melo, FA; Melo, MN; Michalick, MS; Moura, EP; Pimentel, VM; Ribeiro, RR; Sampaio, WM; Schettini, DA; Silva, SM; Tafuri, WL | 1 |
| Steck, EA | 1 |
| García de Miguel, MJ; García Hortelano, J; López-Herce Cid, J; Ramirez Balza, O; Vidal López, ML | 1 |
| Caravagno, C; Maturana, G; Miranda, C; Moyano, C; Osorio, G; Retamales, I; Ubilla, M | 1 |
| Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD; Swartz, GM; Waits, VB | 1 |
| Berman, JD; Hanson, WL; Keenan, CM; Lamb, SR; Waits, VB | 1 |
| Alving, CR; Hanson, WL; Munnell, JF; Weldon, JS | 1 |
| Duvivier, A; Lefèbvre, P; Nemery, A | 1 |
| Kokkini, G; Liosis, G; Papaefstathiou, J; Vrionis, G | 1 |
| Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD | 1 |
| Chapman, WL; Davidson, DE; Hanson, WL; Hendricks, LD; Hockmeyer, WT; Waits, VB | 1 |
| Bódalo Herrero, A; Cambronero Galache, M; Casado Flores, J; Casquero Junquera, J; Courel Grijalba, A; Martínez Cortés, F | 1 |
| Almagro, M; Cabrera Torres, A; De Pablos Gallego, JM; De Puerta, S; Esquivias, JJ; Gómez Morales, M; López Garrido, P | 1 |
| Aram, GN; Arya, LS; Fazal, MI; Goel, RG; Qureshi, MA; Singh, M | 1 |
| Carcassonne, Y; Imbert, C; Sainty, D; Sebahoun, G | 1 |
| Ahmad, E; Ghahramani, N; Javid, R; Malek Hosseini, SA; Nezakatgoo, N; Salahi, H | 1 |
| Berman, JD; Franke, ED; Gasser, RA; Grögl, M; Magill, AJ; Oster, CN | 1 |
| Hernández, DE; Martínez, C; Oliver, M; Planas, G | 1 |
| Bryceson, A; Desjeux, P; Gradoni, L | 1 |
| Cortés, E; Cucurull, E; de Otero, J; Ocaña, I; Pahissa, A; Ribera, E | 1 |
| da Costa, JM; Monjour, L; Neogy, AB; Vouldoukis, I | 1 |
| Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F | 1 |
| Gaeta, GB; Gradoni, L; Maisto, A; Pellizzer, G; Scalone, A | 1 |
| Badaró, F; Badaró, R; Carvalho, JS; Ho, JL; Johnson, WD; Jones, TC; Nascimento, C; Reed, SG; Russo, D | 2 |
| González-Lahoz, JM; Laguna, F; Soriano, V | 1 |
| Ali, A; Berhe, N; Hailu, A; Yeneneh, H | 1 |
| Alvar, J; Boggio, J; González, F; Molina, R; Nieto, J; Rodriguez, F; San Andrés, M; San Andrés, MD; Tesouro, M; Vitutia, M | 1 |
| Closa, JM; Font, A; Gines, C; Mascort, J | 1 |
| Albertini, M; Gari-Toussaint, M; Le Fichoux, Y; Léger, I; Manassero, J; Mariani, R; Marty, P; Tommasi, C | 1 |
| Betto, P; Davidson, RN; Giambenedetti, M; Gradoni, L; Orsini, S | 1 |
| Alvar, J; González-Lahoz, JM; Laguna, F; López-Vélez, R; Montilla, P; Soriano, V | 1 |
| Blanquer, J; Llombart, A; Mesejo, A; Núñez, C; Pérez, PL; Ruiz, F; Simó, M | 1 |
| Barthet, M; Berland, Y; Bernard, JC; Brunet, P; Dussol, B; Jouglard, J; Rodor, F; Sahel, J | 1 |
| Bustamante, SE; Corbett, CE; Duarte, MI | 1 |
| Desmyttere, S; Hachimi-Idrissi, S; Otten, J | 1 |
| Jurado, R; Kindelan, JM; Sanchez-Guijo, P; Torre-Cisneros, J; Villanueva, JL | 1 |
| Edrissian, GH; Movahhed-Danesh, AM; Nadim, A; Soleimanzadeh, G | 1 |
| Alcindor, LG; Ayrault-Jarrier, M; Bekaert, ED; Dubois, DY; Kallel, R; Mebazza, A | 1 |
| Castrillo, JM; de Górgolas, M; Fernández Guerrero, ML | 1 |
| Harhalakis, N; Lazanas, MC; Nikiforakis, E; Papandreou, S; Saroglou, G; Scandali, A; Tsekes, GA | 1 |
| Altieri, S; di Martino, L; Ferrara, M; Gaeta, GB; Gradoni, L; Gramiccia, M; Pempinello, R; Pizzuti, R; Scotti, S | 1 |
| de Lalla, F; Franzetti, M; Gradoni, L; Pellizzer, G; Stecca, C; Vespignani, M | 1 |
| Arnold, P; Deplazes, P; Eckert, J; Lutz, H; Smith, NC | 1 |
| Bourantas, C; Chaliasos, N; Kritikou, E; Lapatsanis, P | 1 |
| Ozsoylu, S | 2 |
| Cortes, E; de Otero, J; Gasser, I; Ocaña, I; Pahissa, A; Ribera, E | 1 |
| Alcázar, R; de la Torre, M; Peces, R | 1 |
| Alberola, J; Arboix, M; Esteban, M; Valladares, JE | 1 |
| Boix, V; Massa, B; Pérez-Mateo, M; Portilla, J; Torrús, D | 1 |
| Derouin, F; Farinotti, R; Gangneux, JP; Garin, YJ; Sulahian, A | 1 |
| Buffet, PA; Derouin, F; Garin, YJ; Nassar, N; Sulahian, A | 1 |
| Dumon, H; Gambarelli, F; Garnier, JM; Kaplanski, S; Piarroux, R; Unal, D | 1 |
| Asensio, C; Bravo, JA; Esteban, RJ; Osuna, A | 1 |
| Brandonisio, O; Ceci, L; Faliero, SM; Fasanella, A; Panunzio, M; Puccini, V | 1 |
| Caramello, P; Millesimo, M; Savoia, D; Zucca, M | 1 |
| Deniau, M; Dumon, H; Faraut-Gambarelli, F; Faugère, B; Giusiano, B; Marty, P; Michel, G; Piarroux, R | 1 |
| Derouin, F; Gangneux, JP; Garin, YJ; Sulahian, A | 2 |
| Abate, O; Buracco, P; Guglielmino, R; Morello, E | 1 |
| Astier, A; Bories, C; Deniau, M; Durand, R; Fusai, T; Houin, R; Paul, M; Rivollet, D | 1 |
| Alcázar, R; Benezet, J; De la Torre, M; Ortega-Carnicer, J | 1 |
| Camma, C; Cascio, A; Giordano, S; Gradoni, L; Gramiccia, M; Russo, R; Scalone, A; Scarlata, F; Titone, L | 1 |
| Chippaux, JP; Djidingar, D; Gragnic, G; Julvez, J; Meynard, D; Tchani, O | 1 |
| Boehringer, C; Bonnefont, C; Bourdoiseau, G; Chabanne, L; Hoareau, E; Stolle, T | 1 |
| Ermak, TN; Filippov, PG; Gruzdev, BM; Kravchenko, AV | 1 |
| Disdier, P; Mary, C; Serratrice, J; Swiader, L; Weiller, PJ | 1 |
| Alberola, J; Arboix, M; Cristòfol, C; Franquelo, C; Gállego, M; Portús, M; Riera, C; Valladares, JE | 1 |
| Ciaramella, P; Cortese, L; de Luna, R; Gradoni, L; Oliva, G; Orsini, S; Persechino, A; Scalone, A | 1 |
| Baghestani, S; Handjani, F; Kumar, PV; Sodeifi, M | 1 |
| Amusategui, I; Sainz, A; Tesouro, MA | 1 |
| Berenguer, J; Cano, J; Fernández Alvarez, JM; Gimeno, M; Gonzalo Lafuente, JC; Vázquez-Piñeiro, T | 1 |
| Dumon, H; Garnier, JM; Minodier, P; Perrimond, H; Piarroux, R; Unal, D | 1 |
| Ahmad, S; Rahim, F; Rehman, F; Zada, B | 1 |
| Derouin, F; Dullin, M; Gangneux, JP; Garin, YJ; Sulahian, A | 1 |
| Bitnun, A; Ephros, M; Shaked, P; Waldman, E; Zilberstein, D | 1 |
| Dumon, H; Faraut-Gambarelli, F; Garnier, JM; Gire, C; Minodier, P; Piarroux, R | 1 |
| Alunda, JM; Cuquerella, M; de la Fuente, C; Fernández-Pérez, FJ; Gómez, MT; Méndez, S | 1 |
| Aoun, K; Belkaid, M; Ben Ismail, R; Bouratbine, A; Bousnina, S; Harrat, Z; Maherzi, A | 1 |
| Chantraine, JM; Dresse, MF; Gillet, P; Hoyoux, C; Marguglio, A; Thiry, A | 1 |
| Belloli, C; Bertini, S; Carli, S; Crescenzo, G; Mengozzi, G; Ormas, P; Zaghini, A | 1 |
| Alvar, J; Gómez-Rodrigo, J; Laguna, F; López-Vélez, R; Medrano, FJ; Pasquau, J; Picó, G; Pulido, F; Salas, A; Sanz, J; Torre-Cisneros, J; Torres, E | 1 |
| Aisa, MJ; Alberola, J; Arboix, M; Carrió, J; Castillejo, S; Fisa, R; Gállego, M; Ribas, N; Riera, C; Valladares, JE | 1 |
| García-Bolao, I; Segura, I | 1 |
| Alsina, J; Bover, J; Gil-Vernet, S; Grinyó, JM; Hueso, M; Rufí, G; Serón, D | 1 |
| Corzo, JE; de la Rosa, R; Delgado, J; González-Moreno, MP; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
| Davidson, RN | 1 |
| Greiner, M; Moritz, A; Steuber, S | 1 |
| Greiner, M; Moritz, A; Schirrmann, I; Steuber, S | 1 |
| González Lahoz, J; Laguna, F; Valencia, ME | 1 |
| Demicheli, C; Frézard, F; Michalick, MS; Soares, CF | 1 |
| Hantson, P; Haufroid, V; Lambert, M; Luyasu, S | 1 |
| Márquez, M; Rivero, A; Santos, J | 1 |
| Alarcón, A; Alvar, J; Bernabeu-Wittel, M; Cordero, E; Prados, D; Regordán, C; Villanueva, JL | 1 |
| Berenguer, J; Cosín, J; López, JC; Miralles, P; Padilla, B | 1 |
| Derouin, F; Gangneux, JP; Garin, YJ; Meneceur, P; Pannier-Stockman, C; Sulahian, A | 1 |
| Aquino, RB; Barbosa, TC; Ferreira, E; Fonseca, G; Lambert, JS; Lucena, S; Nogueira, SA | 1 |
| Alberola, J; Arboix, M; Castillejo, S; Ferrer, L; Fisa, R; Gallego, M; Iniesta, L; Portús, M; Riera, C; Roura, X; Solano-Gallego, L; Valladares, JE | 1 |
| Bakirtaç, A; Kara, C; Kuyucu, N; Teziç, T | 1 |
| Dordain, ML; Rapp, C; Simon, F | 1 |
| Abebe, Y; Abraham, Y; Berhe, N; Breivik, K; Hailu, A; Tadesse, Y | 1 |
| Bevilaqua, CM; Costa, DC; Prata, JR; Rocha, MF; Sidrim, JJ; Simões-Mattos, L; Teixeira, MJ | 1 |
| Fretzayas, A; Karpathios, T; Kitsiou, S; Mathioudakis, J; Moustaki, M | 1 |
| Benítez, MD; de La Rosa, M; Martín, J; Miranda, C; Morillas, F; Navarro, JM | 1 |
| Guerin, JM; Leibinger, F; Masmoudi, R; Mofredj, A | 1 |
| Kafetzis, DA; Maltezou, HC | 1 |
| Basha, M; Bregu, H; Davachi, F; Lita, G; Sulcebe, G | 1 |
| Antinori, S; Cascio, A; Colomba, C; Orobello, M; Paterson, D; Titone, L | 1 |
| Castillo, JA; Gracia, MJ; Guarga, JL; Lucientes, J; Moreno, J; Peribáñez, MA | 1 |
| Gradoni, L; Gramiccia, M; Orsini, S | 1 |
| Bigaignon, G; Cornu, G; Mattot, M; Ninane, J; Vermylen, C | 1 |
| Castillo, R; Hernández-Quero, J; Jiménez, E; Medrano, FJ; Pineda, JA; Reyes, MJ; Rivero, A; Sánchez-Quijano, A; Velez, ID; Viciana, P | 1 |
| Berman, JD; Chapman, WL; Hanson, WL; Ksionski, G; Waits, VB | 1 |
| Bouchouareb, D; Moulin, B; Ollier, J; Olmer, M; Purgus, R | 1 |
| Arnold, P; Deplazes, P; Gessler, M; Skaggs, J | 1 |
| Enriquez, A; García Aguado, C; Gazapo, E; González Lahoz, JM; Laguna, F; Martínez, P; Puente, S | 1 |
| Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N | 1 |
| Casillas, A; Costa, JR; de Dios Garcia, J; del Mar Sanz, M; Guijarro, C; Martinez, R; Rubio, R | 1 |
| Almeida, RP; Badaró, F; Badaró, R; Barral, A; Barral-Netto, M; Carvalho, EM; Falcoff, E; Falcoff, R; Pedral-Sampaio, D; Santos, SB | 1 |
| Gatta, F; Gradoni, L; Gramiccia, M; Lupardini, E; Orsini, S | 1 |
| Betti, F; Gradoni, L; Gramiccia, M | 1 |
| Hanson, WL; Klayman, DL; Lovelace, JK; Vennerstrom, JL; Waits, VB | 1 |
| Gradoni, L; Gramiccia, M; Iorio, MA; Orsini, S | 1 |
| Coutellier, P; Delgrange, B | 1 |
| Berenguer, J; Bernaldo de Quirós, JC; Bouza, E; Cercenado, E; García de la Fuente, A; Moreno, S | 1 |
| Casals, A; Clotet, B; Ribelles, N; Vallés, J | 1 |
| Chulay, JD; Fleckenstein, L; Smith, DH | 1 |
| Chapman, WL; Hanson, WL; White, MR | 1 |
| Kumar, PV; Sadeghi, E; Torabi, S | 1 |
| Bonventre, PF; Nickol, AD | 2 |
| Dupic, Y; Goutner, C; Massip, P; Navarrot, P | 1 |
| Gradoni, L; Gramiccia, M; Mancianti, F; Maroli, M | 1 |
| Anciaux, ML; Bourée, P; Taugourdeau, P | 1 |
| Tsetentis, Y | 1 |
| De Caluwé, JP; Delcourt, A; Heimann, R; Lievens, P; Taelman, H; Trolin, C | 1 |
| Gradoni, L; Gramiccia, M; Mancianti, F; Pieri, S | 2 |
| de la Cruz Amorós, E; Lambruschini Ferri, N; Rodríguez Miguélez, JM; Torres Simón, JM | 1 |
| Hiçsönmez, G; Jama, H; Ozsoylu, S | 1 |
| Arici, C; Bonaccorso, C; Gavazzeni, G; Rizzi, M | 1 |
| Cillari, E; Liew, FY; Lo Campo, P; Mansueto, S; Milano, S; Salerno, A | 1 |
| Alvar, J; González-Lahoz, JM; Polo, RM; Verdejo, J | 1 |
| Berman, JD; Chapman, WL; Hanson, WL; Jackson, JE; Klein, RS; Lovelace, JK; Waits, VB | 1 |
| Mravak, S; Schulzke, I; Weber, B | 1 |
| Ayats, R; Cadafalch, J; Orta, C; Portus, M | 1 |
| Gutiérrez Rodero, F | 1 |
| Davis, JS; De Alencar, JE; Evans, T; Naidu, TG; Pearson, RD; Wheeler, DA | 1 |
| de Souza, PE; Pimentel, PS; Senra, MS | 1 |
| Ben Rachid, MS; Ben Said, M | 1 |
| Adinolfi, LE; Bonventre, PF | 1 |
| Chapman, WL; Hanson, WL; Madindou, TJ | 1 |
| Adinolfi, LE; Bonventre, PF; Eppstein, DA; Vander Pas, M | 1 |
| Gutiérrez Rodero, F; Moya Jeromini, I; Ortiz de la Tabla Ducasse, V; Pozuelo González, A | 1 |
| Ben Salah, N; Katlama, C; Pichard, E; Régnier, B; Vachon, F | 1 |
| Andreoli, A; Bonora, G; Cambiè, M; Gargantini, G; Giaracuni, G; Manzoni, D; Perletti, L | 1 |
21 review(s) available for meglumine antimoniate and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Chemotherapeutics of visceral leishmaniasis: present and future developments.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Meglumine Antimoniate; Paromomycin; Phosphorylcholine; Psychodidae; Sheep; South America; Treatment Outcome | 2018 |
Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Disease Reservoirs; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Molecular Diagnostic Techniques; Organometallic Compounds; Phosphorylcholine; Point-of-Care Systems; Serologic Tests | 2018 |
Evaluating drug resistance in visceral leishmaniasis: the challenges.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine Antimoniate; Parasitic Sensitivity Tests; Phosphorylcholine; Psychodidae; Recurrence | 2018 |
Combination therapy for visceral leishmaniasis.
Topics: Amphotericin B; Antiprotozoal Agents; Asia; Brazil; Cost-Benefit Analysis; Drug Therapy, Combination; Europe; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Safety; South Africa | 2010 |
Leishmaniasis: an update of current pharmacotherapy.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Practice Guidelines as Topic; Species Specificity; Treatment Outcome | 2013 |
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure | 2003 |
[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].
Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Drug Evaluation; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Recurrence; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome | 2004 |
[Visceral leishmaniasis: new drugs].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2003 |
[Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Child; Clinical Trials as Topic; Drug Utilization; Humans; Immunocompetence; Italy; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Practice Patterns, Physicians'; Retrospective Studies; Treatment Outcome | 2004 |
[Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre].
Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cluster Analysis; Disease Outbreaks; Female; Humans; Infant; Italy; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Morbidity; Organometallic Compounds; Retrospective Studies | 2004 |
[Treatment of visceral leishmaniasis in children].
Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
The chemotherapy of protozoal infections: whither?
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Glycolipids; Humans; Leishmaniasis; Leishmaniasis, Visceral; Liposomes; Lysosomes; Malaria; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primaquine; Protozoan Infections; Trypanosomiasis | 1981 |
[Kala-azar. Presentation of 7 cases and review of the literature].
Topics: Antimony; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Organometallic Compounds; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Drug Carriers; Drug Resistance; Follow-Up Studies; HIV-1; Humans; Leishmania; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1993 |
[Treatment of infantile visceral leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Drug Resistance; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors; Treatment Outcome | 1999 |
Visceral leishmaniasis in clinical practice.
Topics: AIDS-Related Opportunistic Infections; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Female; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Substance Abuse, Intravenous | 2000 |
Visceral leishmaniasis in paediatrics.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Child; Disease Vectors; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence | 2002 |
Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
Topics: Adult; Allopurinol; Animals; Antimony; Antiprotozoal Agents; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Methylprednisolone; Muromonab-CD3; Organometallic Compounds | 1992 |
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunocompromised Host; Leishmaniasis, Visceral; Mechlorethamine; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Prednisone; Procarbazine; Vinblastine; Vincristine | 1991 |
[Visceral kala-azar of Spanish origin. Apropos of a case].
Topics: Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1988 |
20 trial(s) available for meglumine antimoniate and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
Topics: Allopurinol; Animals; Cochlea; Creatinine; Dog Diseases; Dogs; Double-Blind Method; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Female; Hearing; Hearing Loss; Injections, Subcutaneous; Kidney; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Neurologic Examination; Paromomycin; Random Allocation; Vestibule, Labyrinth | 2019 |
A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania inf
Topics: Allopurinol; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Injections, Subcutaneous; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Paromomycin; Trypanocidal Agents | 2020 |
Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Artesunate; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Parasite Load; Parasitemia; Zoonoses | 2020 |
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial.
Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Young Adult | 2017 |
Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Monocyclic Sesquiterpenes; Organometallic Compounds; Parasite Load; Sesquiterpenes; Treatment Outcome | 2018 |
Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.
Topics: Child, Preschool; Cohort Studies; Drug Administration Schedule; Humans; Iran; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects; Retrospective Studies | 2017 |
Effects of therapy on haemostasis in dogs infected with Leishmania infantum, Ehrlichia canis, or both combined.
Topics: Allopurinol; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dog Diseases; Dogs; Doxycycline; Drug Combinations; Ehrlichia canis; Ehrlichiosis; Enzyme Inhibitors; Female; Hemostasis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Platelet Aggregation; Treatment Outcome | 2009 |
Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreas | 2009 |
Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.
Topics: Animals; Antiprotozoal Agents; Brazil; Dogs; Immunotherapy; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2010 |
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Bone Marrow; Double-Blind Method; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects; Treatment Outcome | 2003 |
Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2003 |
Are there differences in clinical and laboratory parameters between children and adults with American visceral leishmaniasis?
Topics: Adolescent; Adult; Aging; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2006 |
Treatment of Mediterranean visceral leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Europe; Humans; Infant; Leishmaniasis, Visceral; Liposomes; Mediterranean Islands; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1995 |
Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino.
Topics: Animals; Antigens, Protozoan; Antiprotozoal Agents; Combined Modality Therapy; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Lymphocytes; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1994 |
Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Tests; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Neutropenia; Organometallic Compounds; Superinfection; Treatment Outcome | 1994 |
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Health Care Costs; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Neutropenia; Organometallic Compounds; Pilot Projects; Recombinant Proteins; Severity of Illness Index | 1994 |
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Topics: Adult; Aged; Allopurinol; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Data Interpretation, Statistical; Female; Follow-Up Studies; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Organometallic Compounds; Recurrence; Retrospective Studies; Time Factors | 1996 |
Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Spain; Treatment Outcome | 1999 |
Clinical follow-up examination after treatment of canine leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 1998 |
Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Europe; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies | 2000 |
268 other study(ies) available for meglumine antimoniate and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.
Topics: Allopurinol; Animals; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; Dog Diseases; Dogs; Immunologic Factors; Immunotherapy; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Meglumine Antimoniate; Organometallic Compounds; Polyethylene Glycols; Receptors, Interleukin-10 | 2022 |
Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Female; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Phosphorylcholine | 2021 |
[Generalized old world leishmaniasis: first Moroccan case in an immunocompetent adult?]
Topics: Adult; Amphotericin B; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine Antimoniate | 2021 |
Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
Topics: Allopurinol; Animals; Creatinine; Dog Diseases; Dogs; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Prognosis; Recurrence; Urea | 2023 |
Treatment of leishmaniasis with chemotherapy and vaccine: a mathematical model.
Topics: Antimony Sodium Gluconate; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Models, Biological; Vaccines | 2023 |
Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Biomarkers; Creatinine; Dog Diseases; Dogs; Female; Glomerular Filtration Rate; Kidney Diseases; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate | 2019 |
Adverse reactions to meglumine antimoniate in Brazilian inpatients with visceral leishmaniases: A case series.
Topics: Adolescent; Adult; Antiprotozoal Agents; Brazil; Female; Humans; Inpatients; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Treatment Outcome; Young Adult | 2020 |
First Report of an Urban Case of Canine Visceral Leishmaniasis in the Municipality of Cali, Colombia.
Topics: Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Base Sequence; Cities; Colombia; DNA, Protozoan; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate | 2020 |
Meglumine antimoniate combination treatment for relapsing Kala-azar after treatment and secondary prophylaxis failure with liposomal amphotericin B in two HIV-coinfected patients.
Topics: Adult; Amphotericin B; Atovaquone; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome | 2019 |
Case Report: Combination Therapy with Liposomal Amphotericin B, N-Methyl Meglumine Antimoniate, and Pentamidine Isethionate for Disseminated Visceral Leishmaniasis in a Splenectomized Adult Patient.
Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; Drug Therapy, Combination; Humans; Immunocompromised Host; Intestinal Mucosa; Leishmaniasis, Visceral; Lymph Nodes; Male; Meglumine Antimoniate; Middle Aged; Pentamidine; Splenectomy | 2020 |
LEISHMANICIDAL ACTIVITY in vivo OF A MILTEFOSINE DERIVATIVE IN Mesocricetus auratus.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Cytokines; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Mesocricetus; Phosphorylcholine; Spleen | 2020 |
Treatment and follow-up of a domestic ferret (Mustela putorius furo) with clinical leishmaniosis caused by Leishmania infantum.
Topics: Allopurinol; Animals; Antiparasitic Agents; Drug Therapy, Combination; Female; Ferrets; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Trypanocidal Agents | 2020 |
Serum cobalamin concentrations in dogs with leishmaniosis before and during treatment.
Topics: Allopurinol; Animals; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Vitamin B 12 | 2021 |
Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015.
Topics: Age Distribution; Ambulatory Care Facilities; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Incidence; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sex Distribution; Somalia | 2017 |
Leishmania infantum exerts immunomodulation in canine Kupffer cells reverted by meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Kupffer Cells; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2017 |
Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment.
Topics: Allopurinol; Animals; Dog Diseases; Dogs; Female; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trypanocidal Agents | 2017 |
Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Gene Expression Regulation; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Liver Cirrhosis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Random Allocation; Transforming Growth Factor beta; Vimentin | 2018 |
Sinergism between alkaloids piperine and capsaicin with meglumine antimoniate against Leishmania infantum.
Topics: Alkaloids; Antiprotozoal Agents; Benzodioxoles; Capsaicin; Chromatography, High Pressure Liquid; Drug Synergism; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Magnetic Resonance Spectroscopy; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Piperidines; Polyunsaturated Alkamides; Spectrophotometry, Ultraviolet | 2018 |
Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saliva | 2018 |
Epidemiological and clinical features of visceral leishmaniasis in children in Alicante Province, Spain.
Topics: Adolescent; Amphotericin B; Antibodies, Protozoan; Antiprotozoal Agents; Blood; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Spain | 2018 |
Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Death; Disease Models, Animal; Drug Compounding; Drug Liberation; Female; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Organometallic Compounds; Phosphatidylserines; Tissue Distribution | 2018 |
Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice.
Topics: Animals; Antimony Potassium Tartrate; Antiparasitic Agents; Bone Marrow; Disease Models, Animal; Dogs; Female; Gene Expression Profiling; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liver; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; MicroRNAs; Organometallic Compounds; Parasite Load; Spleen | 2018 |
Potential role of zinc in the visceromegaly regression and recovery of hematological parameters during treatment of visceral leishmaniasis in children from an endemic area.
Topics: Amphotericin B; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Child; Child, Preschool; Dietary Supplements; Endemic Diseases; Female; Humans; Infant; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spleen; Zinc | 2018 |
Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Aryldialkylphosphatase; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Phosphorylcholine | 2019 |
Treatment for human visceral leishmaniasis: a cost-effectiveness analysis for Brazil.
Topics: Amphotericin B; Antiprotozoal Agents; Brazil; Cost-Benefit Analysis; Drug Therapy, Combination; Health Resources; Health Services; Humans; Leishmaniasis, Visceral; Meglumine Antimoniate; Models, Econometric | 2019 |
Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Hypothyroidism; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Thyrotropin; Thyroxine | 2013 |
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Disease Reservoirs; Dog Diseases; Dogs; Drug Combinations; Humans; Immunocompetence; Immunocompromised Host; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine | 2013 |
Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid.
Topics: Animals; Ascorbic Acid; Female; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 2014 |
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles | 2014 |
Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Line; Drug Therapy, Combination; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasite Load; Propolis; Spleen; Water | 2014 |
Papular dermatitis due to Leishmania infantum infection in seventeen dogs: diagnostic features, extent of the infection and treatment outcome.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Dermatitis; DNA, Protozoan; DNA, Ribosomal Spacer; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Molecular Typing; Organometallic Compounds; Prognosis; Protozoan Proteins; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Skin Tests; Treatment Outcome | 2014 |
Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate.
Topics: Animals; Antiparasitic Agents; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Lipase; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreas; Troponin I | 2014 |
Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
Topics: Amphotericin B; Anemia; Antiprotozoal Agents; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Endemic Diseases; Fever; Humans; Infant; Iran; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 2014 |
Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.
Topics: Algeria; Antiprotozoal Agents; Drug Resistance; France; Gene Expression Regulation; Genotype; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Metabolic Networks and Pathways; Organometallic Compounds; Parasitic Sensitivity Tests; Phenotype; Protozoan Proteins; Tunisia | 2014 |
Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Bone Marrow; Chemistry, Pharmaceutical; Dog Diseases; Dogs; Drug Carriers; Drug Delivery Systems; Female; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasite Load; Polyethylene Glycols; Spleen | 2014 |
Preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with visceral leishmaniasis.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Chemokine CCL2; Female; Humans; Inflammation; Kidney; Kidney Diseases; Leishmaniasis, Visceral; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2014 |
The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.
Topics: Adolescent; Adult; Antiprotozoal Agents; Cells, Cultured; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-17; Leishmaniasis, Visceral; Lymphocytes; Male; Meglumine; Meglumine Antimoniate; Monocytes; Nitric Oxide; Organometallic Compounds; Toll-Like Receptor 2; Toll-Like Receptor 4; Transforming Growth Factor beta; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Topics: 3' Untranslated Regions; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Aquaglyceroporins; Aquaporin 1; Cell Movement; Drug Resistance; Gene Expression Regulation; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; RNA, Messenger; RNA, Protozoan | 2015 |
Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum.
Topics: Animals; Anthelmintics; Bibenzyls; Disease Models, Animal; Leishmania infantum; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Phenols; Spleen | 2015 |
[Meeting "Visceral leishmaniasis in Maghreb", 2-4 April 2015 in Tunis. Recommendations].
Topics: Africa, Northern; Amphotericin B; Animals; Antiprotozoal Agents; Developing Countries; Disease Management; Disease Reservoirs; Dog Diseases; Dogs; Drug Substitution; Early Diagnosis; Humans; Immunologic Tests; Insect Control; Insect Vectors; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Zoonoses | 2015 |
[Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
Topics: Amphotericin B; Antiprotozoal Agents; Child, Preschool; Humans; Iran; Iraq; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Turkey | 2015 |
Can Intestinal Intussusception Complicate Visceral Leishmaniasis?
Topics: Antiprotozoal Agents; Child, Preschool; Humans; Ileal Diseases; Intussusception; Laparotomy; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 2016 |
[Evaluation of clinical and laboratory findings of adult visceral leishmaniasis cases].
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Amphotericin B; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Bone Marrow; Female; Humans; Injections, Intramuscular; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult | 2015 |
Tumour Necrosis Factor-alpha (TNF-α) and its soluble receptor type 1 (sTNFR I) in human active and healed leishmaniases.
Topics: Adult; Antiprotozoal Agents; Case-Control Studies; Female; Humans; Interleukin-17; Interleukin-22; Interleukins; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Receptors, Tumor Necrosis Factor, Type I; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2016 |
Visceral Leishmaniasis in Southwestern Iran: A Retrospective Clinico-Hematological Analysis of 380 Consecutive Hospitalized Cases (1999-2014).
Topics: Adolescent; Adult; Aged; Amphotericin B; Bone Marrow Cells; C-Reactive Protein; Child; Child, Preschool; Female; Hospitalization; Humans; Infant; Iran; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancytopenia; Retrospective Studies; Thrombocytopenia; Young Adult | 2016 |
Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; DNA, Protozoan; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Real-Time Polymerase Chain Reaction | 2016 |
Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Cost of Illness; Female; Health Care Costs; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Morocco; Neglected Diseases; Organometallic Compounds | 2016 |
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; Aquaglyceroporins; Dog Diseases; Dogs; Drug Resistance; Gene Expression; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Sulfhydryl Compounds | 2016 |
Leishmaniasis with Femoral Bone Involvement.
Topics: Amphotericin B; Antibodies, Protozoan; Antiprotozoal Agents; Bone Marrow; Femur; Humans; Knee; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
LEISHMANIA INFANTUM INFECTION IN BENNETT'S WALLABIES (MACROPUS RUFOGRISEUS RUFOGRISEUS) IN A SPANISH WILDLIFE PARK.
Topics: Allopurinol; Animals; Animals, Zoo; Female; Insect Vectors; Leishmania infantum; Leishmaniasis, Visceral; Macropodidae; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae; Spain | 2016 |
An 8-Year Retrospective Study of Human Visceral Leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Coinfection; Female; HIV Infections; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Retrospective Studies; Sex Distribution; Young Adult | 2016 |
Clinical and Epidemiologic Features of Visceral Leishmaniasis in Children in Southwestern China: A Retrospective Analysis From 2001 to 2015.
Topics: Antiprotozoal Agents; Biopsy; Bone Marrow; Child; Child, Preschool; China; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies | 2017 |
Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Iran; Leishmania donovani; Leishmaniasis, Visceral; Liver Function Tests; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Seasons | 2008 |
Detection of Leishmania kDNA in human serum samples for the diagnosis of visceral leishmaniasis.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Brazil; Child; Child, Preschool; DNA, Kinetoplast; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Polymerase Chain Reaction; Sensitivity and Specificity; Young Adult | 2009 |
Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Interferon-gamma; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2008 |
Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil.
Topics: Acute Kidney Injury; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Ureohydrolases | 2008 |
[Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us].
Topics: Animals; Antiprotozoal Agents; Comorbidity; Disease Reservoirs; Dog Diseases; Dogs; Drug Utilization; HIV Infections; Humans; Incidence; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain | 2009 |
[Raised tattoos in a human-immunodeficiency-virus-infected patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Hepatitis C, Chronic; Histiocytes; Humans; Lamivudine; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lopinavir; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Compliance; Pentamidine; Pyrimidinones; Recurrence; Ritonavir; Tattooing; Zidovudine | 2009 |
Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Cardiovascular Abnormalities; Child; Child, Preschool; Electrocardiography; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2009 |
Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.
Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Heart; Humans; Leishmaniasis, Visceral; Liver Failure; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Renal Insufficiency | 2009 |
AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
Topics: Amphotericin B; Amyloidosis; Anti-HIV Agents; Antiprotozoal Agents; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2009 |
Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Asthenia; Bone Marrow; Brazil; CD4 Lymphocyte Count; Cough; Diarrhea; Female; Fever; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancytopenia; Retrospective Studies; Splenomegaly; Time Factors; Weight Loss | 2009 |
Short report: Contribution of quantitative real-time polymerase chain reaction to follow-up of visceral leishmaniasis patients treated with meglumine antimoniate.
Topics: Antiprotozoal Agents; DNA, Protozoan; Follow-Up Studies; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction | 2009 |
Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.
Topics: Allopurinol; Bone Marrow Examination; Humans; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Time Factors; Treatment Outcome; Trypanocidal Agents; Tunisia | 2010 |
Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
Topics: Adolescent; Age Distribution; Amphotericin B; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Treatment Outcome; Turkey | 2009 |
Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Kidney Diseases; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Young Adult | 2010 |
[Visceral leishmaniasis in immunocompetent adult with severe sepsis].
Topics: Antiprotozoal Agents; Echocardiography; Humans; Immunocompetence; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sepsis | 2010 |
[Visceral childhood leishmaniasis: diagnosis and treatment].
Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies | 2010 |
Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil.
Topics: Adolescent; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2010 |
HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antiprotozoal Agents; Brazil; CD4 Lymphocyte Count; Endemic Diseases; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Viral Load; Young Adult | 2010 |
Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009).
Topics: Adolescent; Albania; Amphotericin B; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Microscopy; Organometallic Compounds; Parasitology; Retrospective Studies; Serologic Tests | 2010 |
Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Comorbidity; Ethiopia; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Renal Insufficiency; Treatment Outcome; Young Adult | 2010 |
[Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Drug Therapy, Combination; Etoposide; Fatal Outcome; Glucocorticoids; Humans; Immunoglobulins; Infant; Leishmania; Leishmaniasis, Visceral; Lymphohistiocytosis, Hemophagocytic; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2010 |
Risk factors for relapse of visceral leishmaniasis in Georgia.
Topics: Age Factors; Antiprotozoal Agents; Child; Child, Preschool; Delayed Diagnosis; Female; Georgia (Republic); Hemoglobins; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Recurrence; Risk Factors | 2011 |
[Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].
Topics: Adult; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antiprotozoal Agents; Antiviral Agents; Epstein-Barr Virus Infections; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Lymphoproliferative Disorders; Male; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Postoperative Complications; Remission Induction; Rituximab; Sirolimus | 2011 |
Detection of Leishmania amastigotes in peripheral blood from four dogs--Short communication.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Fatal Outcome; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2011 |
The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Leishmania infantum; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thiadiazoles; Treatment Outcome | 2012 |
Serological monitoring of paediatric visceral leishmaniasis By IFA and ELISA methods.
Topics: Adolescent; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; DNA, Protozoan; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Turkey | 2011 |
In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure.
Topics: Algeria; Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2012 |
Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dogs; Female; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2012 |
Tongue nodules in canine leishmaniosis--a case report.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tongue; Tongue Diseases | 2012 |
Evaluation of the cardiac toxicity of N-methyl-glucamine antimoniate in dogs with naturally occurring leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Electrocardiography; Heart; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Troponin I | 2013 |
Comparative analysis of pediatric and adult visceral leishmaniasis in Brazil.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Treatment Outcome | 2013 |
Quantification of Leishmania infantum kinetoplast DNA for monitoring the response to meglumine antimoniate therapy in visceral leishmaniasis.
Topics: Antiprotozoal Agents; Child; Child, Preschool; DNA, Kinetoplast; Female; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Real-Time Polymerase Chain Reaction; Treatment Outcome | 2013 |
Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bradycardia; Child; Electrocardiography; Ethiopia; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2001 |
Distribution of liposome-encapsulated antimony in dogs.
Topics: Animals; Antiprotozoal Agents; Biological Availability; Chemistry, Pharmaceutical; Dog Diseases; Dogs; Freeze Drying; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2003 |
Post-kala-azar dermal leishmaniasis associated with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2002 |
[Obstructive acute renal failure revealing visceral leishmaniasis in a diabetic patient].
Topics: Acute Kidney Injury; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Diabetes Mellitus, Type 1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed | 2003 |
[N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain | 1952 |
[Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
Topics: Antimony; Hypersensitivity; Immune System Diseases; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1954 |
[Two cases of kala-azar treated with glucantime].
Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Test treatment with N-methylglucamine antimoniate in the diagnosis of kala-azar in children].
Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1958 |
[8 cases of kala-azar cured with glucantime].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1962 |
[N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba].
Topics: Antimony; Humans; Islands; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
Visceral leishmaniasis treatment, Italy.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Drug Combinations; Drug Therapy; Humans; Italy; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2003 |
[Treatment of kala-azar by glucantime].
Topics: Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1950 |
[Polyneuritic complications after treatment of kala-azar in the adult with 2168 R.P].
Topics: Adult; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Neuritis; Organometallic Compounds; Polyneuropathies | 1951 |
[Use of glucantime in infantile kala-azar].
Topics: Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1951 |
[Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy].
Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; Female; Humans; Immunocompetence; Infant; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Recurrence | 2004 |
Leishmaniasis of the lip in a patient with Down's syndrome.
Topics: Animals; Antiprotozoal Agents; Diagnosis, Differential; Down Syndrome; Female; Humans; Injections, Intramuscular; Leishmania infantum; Leishmaniasis, Visceral; Lip Diseases; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2004 |
[Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B].
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Follow-Up Studies; HIV Seropositivity; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Time Factors | 2004 |
Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Topics: Adolescent; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Female; Greece; Humans; Infant; Infant, Newborn; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2005 |
Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
Topics: Antiprotozoal Agents; Bone Marrow; Bone Marrow Diseases; Fatal Outcome; Glucocorticoids; HIV Seronegativity; Humans; Hypotension; Immunocompromised Host; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive | 2005 |
[Spontaneous rupture of the spleen in a patient with visceral leishmaniasis].
Topics: Aged; Animals; Antiprotozoal Agents; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radiography; Rupture, Spontaneous; Spleen; Splenic Rupture; Treatment Outcome | 2005 |
Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fluoroquinolones; Interleukin-6; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Nitric Oxide; Organometallic Compounds; Parasitic Sensitivity Tests; Quinolones; Tumor Necrosis Factor-alpha | 2006 |
Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 2005 |
Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Bone Marrow; Dog Diseases; Dogs; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spectrophotometry, Atomic | 2005 |
Childhood visceral leishmaniasis in Muzaffarabad, Azad Jammu and Kashmir: frequency and response to treatment in 61 cases.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Drug Resistance; Female; Hospitals, Military; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pakistan; Treatment Outcome | 2005 |
Side effects of treatment with antimony salts.
Topics: Antiprotozoal Agents; Arrhythmias, Cardiac; Hepatomegaly; Humans; Hypokalemia; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 1989 |
Our experiences in visceral leishmaniasis therapy.
Topics: Antiprotozoal Agents; Child; Hospitals, Pediatric; Humans; Italy; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sicily | 1989 |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Infant; Interferon-gamma; Interleukin-10; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organ Size; Organometallic Compounds; Prospective Studies; Spleen; Time Factors | 2005 |
[Functional status of haemostasis system in patients with visceral leishmaniasis].
Topics: Adolescent; Antiprotozoal Agents; Child; Hemostasis; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prothrombin Time; Thrombocytopenia | 2005 |
Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-12; Leishmania major; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thalidomide; Time Factors | 2006 |
Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Diagnosis, Differential; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2006 |
[Visceral leishmaniasis in an immunocompetent subject, acquired in the Pyrenees region].
Topics: Adult; Animals; Antiprotozoal Agents; Female; France; Hepatomegaly; Humans; Immunocompetence; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 2006 |
Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Carrier State; Disease Reservoirs; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Time Factors; Treatment Outcome | 2007 |
Immunologic tests in patients after clinical cure of visceral leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Chromatography; Dogs; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunologic Tests; Infant; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Skin Tests; Time Factors | 2006 |
[Visceral leishmaniasis with cardiac affectation in an immunocompetent patient].
Topics: Adult; Animals; Antiprotozoal Agents; Echocardiography; Humans; Immunocompetence; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Myocarditis; Organometallic Compounds; Treatment Outcome | 2006 |
Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Kidney; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2007 |
Visceral leishmaniasis: bone marrow biopsy findings.
Topics: Amphotericin B; Antiprotozoal Agents; Biopsy; Bone Marrow; Bone Marrow Examination; Child; Child, Preschool; Female; Fibrosis; Granuloma; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Necrosis; Organometallic Compounds; Prognosis; Retrospective Studies | 2007 |
Kala-azar control, Uganda.
Topics: Adolescent; Agglutination Tests; Animals; Antibodies, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Injections, Intramuscular; Isoptera; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Reagent Kits, Diagnostic; Risk Factors; Seroepidemiologic Studies; Travel; Uganda | 2007 |
An HIV-positive man with tattoo induration.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing | 2007 |
The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Homeostasis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Platelet Aggregation; Prednisone; Random Allocation; Risk Assessment | 2008 |
[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002].
Topics: Adult; Amphotericin B; Anemia; Animals; Antimony; Antiprotozoal Agents; Fever; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Splenomegaly; Treatment Outcome; Tunisia | 2007 |
Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.
Topics: Adult; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Treatment Outcome | 2008 |
Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Kenya; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Statistics as Topic; Treatment Outcome; Uganda | 2008 |
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Immunotherapy; Leishmania infantum; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Survival Rate; T-Lymphocytes; Vaccines, Synthetic | 2008 |
[An atypical presentation of visceral leshmaniasis in an immunocompetent patient].
Topics: Adolescent; Animals; Fatal Outcome; Female; Humans; Immunocompetence; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2008 |
A simple duplex-PCR protocol for routine diagnosis and follow up of canine leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; DNA, Kinetoplast; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Lymph Nodes; Lymphadenitis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Phosphoric Monoester Hydrolases; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity | 2007 |
Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Insect Vectors; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus | 2008 |
[Visceral leishmaniasis (kala-azar): 1st case observed in Chile].
Topics: Adult; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 1984 |
Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Leishmania; Leishmaniasis, Visceral; Liposomes; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Virulence | 1984 |
Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antimony; Bilirubin; Bone Marrow; Cricetinae; Drug Evaluation, Preclinical; Formycins; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds | 1983 |
Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway.
Topics: Animals; Antimony; Cricetinae; Kupffer Cells; Leishmania; Leishmaniasis, Visceral; Liposomes; Lysosomes; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Microscopy, Electron; Organometallic Compounds; Phagocytosis; Spleen | 1983 |
[A case of visceral leishmaniasis].
Topics: Aged; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1984 |
Cold agglutinin syndrome and hemophagocytosis in systemic leishmaniasis.
Topics: Anemia, Hemolytic, Autoimmune; Antimony; Bone Marrow Cells; Child, Preschool; Histiocytes; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phagocytosis | 1984 |
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog.
Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1984 |
Relative insensitivity of a Kenyan strain of Leishmania donovani to pentavalent antimony therapy in hamsters.
Topics: Animals; Antimony; Cricetinae; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1983 |
[Kala-azar in childhood. 20 year review].
Topics: Adolescent; Age Factors; Aniline Compounds; Antimony; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sex Factors; Spain; Stilbenes | 1983 |
[Kala-azar and autoimmune hemolytic anemia. Apropos of a fatally developing case caused by hepatotoxicity from N-methylglucamine antimonate].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antimony; Chemical and Drug Induced Liver Injury; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1982 |
Kala-azar in Afghanistan.
Topics: Afghanistan; Antimony; Antiprotozoal Agents; Child, Preschool; Female; Hepatomegaly; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 1982 |
[Adult Mediterranean visceral leishmaniasis: report of 12 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Antimony; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1980 |
A case report of Kala-Azar in a kidney transplant patient.
Topics: Adult; Allopurinol; Antiprotozoal Agents; Follow-Up Studies; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Splenectomy; Splenomegaly; Time Factors | 1995 |
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
Topics: Adult; Amylases; Antimony Sodium Gluconate; Antiprotozoal Agents; District of Columbia; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Peru; Prospective Studies | 1994 |
Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antineoplastic Agents; Antiprotozoal Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins; Rectal Diseases | 1995 |
[Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Enzyme Tests; Female; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence | 1995 |
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous | 1994 |
Mediterranean visceral leishmaniasis in pregnancy.
Topics: Adult; Amphotericin B; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Female; Humans; Infant, Newborn; Italy; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pregnancy; Pregnancy Complications, Parasitic; Serologic Tests | 1994 |
Misdiagnosis of pancreatitis in patients receiving treatment with pentavalent antimonial agents.
Topics: Diagnostic Errors; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Prospective Studies | 1994 |
Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
Topics: Adolescent; Adult; Age Factors; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; Follow-Up Studies; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Sex Factors; Treatment Outcome | 1994 |
Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Time Factors; Treatment Outcome | 1994 |
Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Topics: Animals; Antimony; Antiprotozoal Agents; Disseminated Intravascular Coagulation; Dog Diseases; Dogs; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1994 |
[Childhood visceral leishmaniasis in the Alpes-Maritimes from 1985 to 1992].
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies | 1994 |
Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice.
Topics: Amphotericin B; Animals; Cricetinae; HIV Infections; Humans; Infant, Newborn; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Spleen; Tissue Distribution | 1993 |
Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Injections, Intramuscular; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects | 1994 |
[Visceral leishmaniasis and multiple organ failure].
Topics: Adolescent; Animals; Bone Marrow; Disseminated Intravascular Coagulation; Fatal Outcome; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Multiple Organ Failure; Organometallic Compounds | 1993 |
[Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
Topics: Acute Disease; Adult; Animals; Antiprotozoal Agents; Female; Humans; Immune Tolerance; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1994 |
Regression of diffuse intralobular liver fibrosis associated with visceral leishmaniasis.
Topics: Adolescent; Animals; Antigens, Protozoan; Brazil; Hepatomegaly; Humans; Immunohistochemistry; Kupffer Cells; Leishmania infantum; Leishmaniasis, Visceral; Liver; Liver Cirrhosis; Male; Meglumine; Meglumine Antimoniate; Microscopy, Electron; Organometallic Compounds; Splenomegaly | 1993 |
[Visceral leishmaniasis: a possible diagnosis in Belgium].
Topics: Antimony; Antiprotozoal Agents; Diagnosis, Differential; Female; Humans; Infant; Leishmaniasis, Visceral; Leukemia; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1993 |
Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection.
Topics: Adolescent; Adult; Agglutination Tests; Ambulatory Care; Antiprotozoal Agents; Bone Marrow Examination; Child; Child, Preschool; Female; Fluorescent Antibody Technique; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Iran; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Population Surveillance | 1993 |
Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Apolipoproteins; C-Reactive Protein; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1993 |
Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; HIV-1; Humans; Interferon-gamma; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1993 |
Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Dosage Forms; Female; Humans; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1993 |
The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing.
Topics: Adolescent; Adult; Allopurinol; Animals; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Female; Humans; Infant; Infant, Newborn; Isoenzymes; Italy; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Population Surveillance; Seasons; Skin Tests | 1993 |
Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
Topics: Acute Disease; Adult; Antimony; Antiprotozoal Agents; Female; Ghana; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1993 |
Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites.
Topics: Animals; Antibodies, Helminth; Antibodies, Protozoan; Antiprotozoal Agents; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Immunoglobulin G; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Toxoplasmosis, Animal | 1995 |
A 7-month-old girl with fever and bleeding.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dicloxacillin; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Diseases | 1996 |
Treatment of kala azar.
Topics: Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1996 |
Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis.
Topics: Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Antitubercular Agents; Humans; Kidney Failure, Chronic; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Remission Induction; Renal Dialysis; Tuberculosis, Renal | 1996 |
Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
Topics: Animals; Antimony; Antiprotozoal Agents; Biological Availability; Dog Diseases; Dogs; Half-Life; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1996 |
Meglumine antimoniate-induced pancreatitis.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1996 |
Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Carriers; Female; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 1996 |
Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver Diseases, Parasitic; Lung Diseases, Parasitic; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitology; Paromomycin; Splenic Diseases | 1996 |
[Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management].
Topics: Animals; Antiprotozoal Agents; Drug Resistance; Female; Humans; Immunity, Cellular; Infant; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Recurrence | 1996 |
Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure.
Topics: Antiprotozoal Agents; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Opportunistic Infections; Organometallic Compounds | 1996 |
Evaluation of polymorphonuclear cell and monocyte functions in Leishmania infantum-infected dogs.
Topics: Animals; Antiprotozoal Agents; Cytotoxicity, Immunologic; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Monocytes; Neutrophils; Organometallic Compounds; Phagocytosis; Respiratory Burst | 1996 |
Evaluation of the immune response in visceral leishmaniasis.
Topics: Agglutination Tests; Animals; Antiprotozoal Agents; Clinical Laboratory Techniques; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Fluorescent Antibody Technique, Indirect; Humans; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Sensitivity and Specificity; T-Lymphocytes | 1996 |
In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Polymerase Chain Reaction | 1997 |
Activity of IFN-gamma in experimental Leishmania infantum murine visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Administration Schedule; Female; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Liver; Lung; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Recombinant Proteins; Spleen | 1997 |
Osteomyelitis and arthrosynovitis associated with Leishmania donovani infection in a dog.
Topics: Animals; Antiprotozoal Agents; Diarrhea; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteomyelitis; Pain; Radiography; Radius; Synovial Fluid; Synovitis; Tibia; Ulna | 1997 |
Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model.
Topics: Animals; Antimony; Antiprotozoal Agents; Colloids; Disease Models, Animal; Drug Carriers; Female; Leishmania major; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Pentamidine; Polymethacrylic Acids; Random Allocation | 1994 |
Pentavalent antimonial-induced torsade de pointes.
Topics: Aged; Anti-Arrhythmia Agents; Antimony; Antiprotozoal Agents; Electrocardiography; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Torsades de Pointes | 1997 |
Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy.
Topics: Adolescent; Adult; Age Distribution; Aged; Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Sex Distribution; Sicily | 1997 |
[Visceral leishmaniasis in Niger: six new parasitologically confirmed cases].
Topics: Adult; Antiprotozoal Agents; Bone Marrow; Fatal Outcome; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Niger; Organometallic Compounds; Prevalence | 1997 |
Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Paromomycin; Spleen | 1997 |
Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs.
Topics: Animals; Antibodies, Protozoan; Antibody Formation; Antiprotozoal Agents; B-Lymphocytes; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunity, Cellular; Immunoglobulin G; Leishmania infantum; Leishmaniasis, Visceral; Lymphocyte Subsets; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; T-Lymphocytes | 1997 |
[The first case of visceral leishmaniasis in a patient with HIV infection in Russia].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Biopsy; Bone Marrow; HIV-1; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1997 |
Pseudo-acute transformation of an idiopathic myelofibrosis due to kala-azar.
Topics: Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primary Myelofibrosis | 1998 |
Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
Topics: Analysis of Variance; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Administration Schedule; Injections, Subcutaneous; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Metabolic Clearance Rate; Organometallic Compounds | 1998 |
Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Outcome | 1998 |
Post-kala-azar dermal leishmaniasis.
Topics: Antiprotozoal Agents; Biopsy, Needle; Child, Preschool; Humans; Iran; Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1998 |
Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Topics: Allopurinol; Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Serum Albumin; Serum Globulins; Time Factors | 1998 |
Visceral leishmaniasis: a lingual presentation in a patient with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimony; Antiprotozoal Agents; Didanosine; HIV Infections; Humans; Laryngitis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Tongue Diseases; Zidovudine | 1998 |
Pediatric visceral leishmaniasis in southern France.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Failure; Treatment Outcome | 1998 |
Visceral leishmaniasis in District Dir, NWFP.
Topics: Abdomen; Anemia; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; Fever; Hepatomegaly; Humans; Hypergammaglobulinemia; Leishmania donovani; Leishmaniasis, Visceral; Leukopenia; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pakistan; Splenomegaly; Thrombocytopenia; Weight Loss | 1998 |
Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.
Topics: Animals; Drug Synergism; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Spleen; Trypanocidal Agents | 1999 |
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenites; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
Value of Western blotting in the clinical follow-up of canine leishmaniasis.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Blotting, Western; Disease Progression; Dog Diseases; Dogs; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sensitivity and Specificity; Treatment Outcome | 1999 |
[Confirmation of the presence of Leishmania infantum MON-80 in Tunisia].
Topics: Animals; Antiprotozoal Agents; Blood Transfusion; Child, Preschool; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tunisia | 1999 |
[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma].
Topics: Amphotericin B; Antifungal Agents; Antimony; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Child; Chronic Disease; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Lung Neoplasms; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteosarcoma; Recurrence; Spinal Neoplasms | 1998 |
Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs.
Topics: Amebicides; Animals; Antimony; Antiprotozoal Agents; Area Under Curve; Chromatography, Liquid; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluorometry; Half-Life; Injections, Subcutaneous; Least-Squares Analysis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Spectrophotometry, Atomic | 1999 |
Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Biopsy; Blood; Blotting, Western; Dog Diseases; Dogs; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Leishmania infantum; Leishmaniasis, Visceral; Lymph Nodes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin | 1999 |
Meglumine antimoniate, amiodarone and torsades de pointes: a case report.
Topics: Aged; Amiodarone; Antiprotozoal Agents; Electrocardiography; Follow-Up Studies; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Remission, Spontaneous; Torsades de Pointes | 1999 |
The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
Topics: Aged; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Ketoconazole; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
Topics: Adult; Amylases; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Creatinine; Female; HIV Infections; HIV-1; Humans; Leishmania infantum; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence; Retrospective Studies; Vomiting | 1999 |
PCR follow-up examination after treatment of canine leishmaniosis (CaL).
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Sensitivity and Specificity; Species Specificity | 1998 |
[Nephrotic syndrome and acute pancreatitis related to glucantime administration].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Nephrotic Syndrome; Organometallic Compounds; Pancreatitis | 2000 |
Novel methods for the encapsulation of meglumine antimoniate into liposomes.
Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Cricetinae; Dehydration; Drug Compounding; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds | 2000 |
Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy.
Topics: Antimony; Antiprotozoal Agents; Creatinine; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Oliguria; Organometallic Compounds; Renal Insufficiency; Shock, Septic | 2000 |
Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Chemoprevention; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome | 2000 |
Assessment of Leishmania promastigote growth in vitro by means of nucleoside hydrolase activity determination.
Topics: Animals; Antiprotozoal Agents; Culture Media; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; N-Glycosyl Hydrolases; Organometallic Compounds; Parasitic Sensitivity Tests; Ribose | 2001 |
Visceral leishmaniasis in a Brazilian child infected perinatally with human immunodeficiency virus.
Topics: Antiprotozoal Agents; Brazil; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2001 |
Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antibody Specificity; Antiprotozoal Agents; Dog Diseases; Dogs; Endemic Diseases; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Leishmania infantum; Leishmaniasis, Visceral; Longitudinal Studies; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Seroepidemiologic Studies; Spain | 2001 |
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Topics: Acute Disease; Allopurinol; Antiprotozoal Agents; Child, Preschool; Humans; Ketoconazole; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 2001 |
[N-methyl glucamine antimoniate or Glucantime].
Topics: Antiprotozoal Agents; Drug Interactions; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Selection; Treatment Outcome | 2000 |
Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study.
Topics: Adolescent; Adult; Ambulatory Care; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cross Infection; Ethiopia; Female; Hospitalization; Humans; Infant; Infant, Newborn; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rural Population; Treatment Outcome; Urban Population | 2001 |
Evaluation of terbinafine treatment in Leishmania chagasi-infected hamsters (Mesocricetus auratus).
Topics: Animals; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Naphthalenes; Organ Size; Organometallic Compounds; Random Allocation; Spleen; Terbinafine; Treatment Outcome; Trypanocidal Agents; Zoonoses | 2002 |
Splenic granulomatous lesions in immunocompetent pediatric patients with visceral leishmaniasis.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Granuloma; Humans; Immunocompetence; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Splenic Diseases; Treatment Outcome | 2001 |
[Isolated laringeal leishmaniasis and bone marrow culture (reply)].
Topics: Adult; Animals; Antiprotozoal Agents; Biopsy; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Humans; Laryngeal Diseases; Larynx; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2002 |
Visceral leishmaniasis with pericarditis in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Candidiasis; HIV Infections; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pericarditis | 2002 |
Pediatric visceral leishmaniasis in Albania.
Topics: Agglutination Tests; Albania; Antiprotozoal Agents; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sensitivity and Specificity | 2002 |
Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Nutrition Disorders; Organometallic Compounds; Recurrence; Retrospective Studies; Sicily; Treatment Outcome | 2002 |
Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cell Division; Diptera; Dog Diseases; Dogs; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Immunotherapy; Leishmania infantum; Leishmaniasis, Visceral; Lymphocyte Subsets; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2002 |
Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
Topics: Animals; Antiprotozoal Agents; Disease Reservoirs; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance; Female; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 1992 |
Visceral and cutaneous leishmaniasis in an European paediatric population.
Topics: Animals; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1992 |
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Topics: Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; Female; HIV-1; Hospitals, University; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Retrospective Studies; Spain; Treatment Outcome | 1992 |
Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cholesterol Esters; Cricetinae; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Treatment of visceral leishmaniasis.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
[Parasitological and immunological progress control during and after chemotherapy of canine leishmaniasis].
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania donovani; Leishmaniasis, Visceral; Lymph Nodes; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
[Visceral leishmaniasis: a study of 15 cases].
Topics: Age Factors; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Serologic Tests; Sex Factors; Spain | 1992 |
Visceral leishmaniasis in HIV-infected patients.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Spain; Treatment Outcome | 1991 |
Tumor necrosis factor (cachectin) in human visceral leishmaniasis.
Topics: Acute Disease; Antimony; Antiprotozoal Agents; Cells, Cultured; Combined Modality Therapy; Female; Humans; Interferon-gamma; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |
Synthesis and antileishmanial activity of some 1- or 2-(dihydroxyalkyl) and 3-(dihydroxyalkoxy)pyrazolo [3,4-d] pyrimidines.
Topics: Animals; Antiprotozoal Agents; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 1991 |
Fatal visceral disease caused by a dermotropic Leishmania in a patient with human immunodeficiency virus infection.
Topics: Adult; Animals; Antiprotozoal Agents; HIV Infections; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1990 |
Berberine derivatives as antileishmanial drugs.
Topics: Animals; Antiprotozoal Agents; Berberine; Berberine Alkaloids; Body Weight; Cricetinae; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin | 1990 |
In vivo effect of eflornithine (DFMO) and some related compounds on Leishmania infantum preliminary communication.
Topics: Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Eflornithine; Leishmania donovani; Leishmaniasis, Visceral; Magnetic Resonance Spectroscopy; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 1989 |
[Kala-azar. Apropos of a case report in a Belgian woman].
Topics: Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol | 1989 |
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Opportunistic Infections; Organometallic Compounds; Serologic Tests; Spain; Trypanocidal Agents | 1989 |
[Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
Topics: Acquired Immunodeficiency Syndrome; Adult; Allopurinol; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis | 1989 |
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Gluconates; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Chemotherapy of experimental visceral leishmaniasis in the opossum.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Body Weight; Female; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Opossums; Organ Size; Organometallic Compounds; Sorbitol; Spleen | 1989 |
Kala azar with disseminated dermal leishmaniasis.
Topics: Adolescent; Antiprotozoal Agents; Biopsy; Child; Female; Humans; Iran; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin; Sorbitol | 1989 |
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells.
Topics: Animals; Antigens, Protozoan; Antimony; Immune Tolerance; Interleukin-2; Leishmania donovani; Leishmaniasis, Visceral; Lymphocyte Activation; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred Strains; Organometallic Compounds; Spleen; T-Lymphocytes, Regulatory | 1985 |
[Kala-azar in pregnant women].
Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pregnancy; Pregnancy Complications, Infectious | 1986 |
Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Insect Vectors; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus | 1987 |
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy | 1985 |
[Treatment of visceral leishmaniasis].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Pentamidine | 1985 |
Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Fluorescent Antibody Technique; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1988 |
[Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
Topics: Allopurinol; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunologic Tests; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Severe leucopenia during treatment of visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmaniasis, Visceral; Leukocyte Count; Leukopenia; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Visceral leishmaniasis in a patient with human immunodeficiency virus.
Topics: Adult; AIDS-Related Complex; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1988 |
Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Italy; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1988 |
Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily.
Topics: Adult; Aged; Female; Freezing; Humans; Interleukin-1; Interleukin-2; Leishmaniasis, Visceral; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phytohemagglutinins; Tissue Preservation | 1988 |
Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
Topics: Antimony; Antiprotozoal Agents; Humans; Immune Tolerance; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Activity of purine analogs against Leishmania donovani in vivo.
Topics: Administration, Oral; Allopurinol; Animals; Cricetinae; Formycins; Guanosine; Injections, Intramuscular; Inosine; Leishmania donovani; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Saimiri; Spleen | 1987 |
[Kala-azar with marked ferritinemia in a German school child].
Topics: Anemia, Hypochromic; Child; Ferritins; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1987 |
[Visceral leishmaniasis mimicking histiocytic marrow reticulosis].
Topics: Adult; Antimony; Bone Marrow; Diagnosis, Differential; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Lymphatic Diseases; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phagocytosis | 1986 |
[Agranulocytosis caused by glucantime in the treatment of kala-azar].
Topics: Agranulocytosis; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
Humoral factors during South American visceral leishmaniasis.
Topics: Adolescent; Adult; Antibodies; Antigen-Antibody Complex; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Complement Fixation Tests; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rheumatoid Factor | 1986 |
[Visceral leishmaniasis in Santarem/PA: general aspects of the control, serological survey in dogs and treatment of the human cases].
Topics: Adolescent; Adult; Animals; Brazil; Child; Child, Preschool; Dog Diseases; Dogs; Humans; Infant; Insect Control; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Psychodidae | 1985 |
[Value of the ELISA IgG and IgM test in the diagnosis and post-therapeutic monitoring of kala-azar].
Topics: Antimony; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunoglobulin G; Immunoglobulin M; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rheumatoid Factor | 1985 |
Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1).
Topics: Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis, Visceral; Lymphokines; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Organometallic Compounds; Piperidines; Thioglycolates | 1985 |
Chemotherapy of visceral leishmaniasis (Leishmania donovani) in the squirrel monkey (Saimiri sciureus).
Topics: Animals; Antimony; Antiprotozoal Agents; Female; Leishmania; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saimiri | 1985 |
Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Combined Modality Therapy; Cricetinae; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds | 1985 |
[Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
Topics: Adult; Agranulocytosis; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
Immunosuppression associated with visceral leishmaniasis of hamsters.
Topics: Animals; Antigens, Protozoan; Antimony; Cricetinae; Immune Tolerance; Leishmania; Leishmaniasis, Visceral; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors | 1985 |
[Toxicity of Glucantime. A case].
Topics: Adult; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
[Description of a case of visceral leishmaniasis. Epidemiologic, diagnostic and therapeutic considerations].
Topics: Antimony; Child, Preschool; Humans; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |